HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure.
作者信息
Anwar Nadeem, Sherman Kenneth E
机构信息
University of Cincinnati College of Medicine Department of Internal Medicine, Division of Digestive Diseases Cincinnati OH.
出版信息
Clin Liver Dis (Hoboken). 2014 Oct 24;4(4):80-83. doi: 10.1002/cld.397. eCollection 2014 Oct.
Abstract
摘要
相似文献
1
HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure.
Clin Liver Dis (Hoboken). 2014 Oct 24;4(4):80-83. doi: 10.1002/cld.397. eCollection 2014 Oct.
2
Hepatitis C virus-HIV-coinfected patients and liver transplantation.
Curr Opin Organ Transplant. 2015 Jun;20(3):276-85. doi: 10.1097/MOT.0000000000000199.
3
Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
AIDS. 2016 Jan 2;30(1):93-8. doi: 10.1097/QAD.0000000000000887.
4
Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.
Transplant Proc. 2012 Sep;44(7):2100-2. doi: 10.1016/j.transproceed.2012.07.074.
5
HIV-HCV RNA loads and liver failure in coinfected patients with coagulopathy.
Haematologica. 1999 Jun;84(6):525-9.
6
Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy.
AIDS. 2003 Nov 7;17(16):2279-90. doi: 10.1097/00002030-200311070-00002.
7
Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
Clin Infect Dis. 2015 Oct 1;61(7):1054-62. doi: 10.1093/cid/civ471. Epub 2015 Jun 16.
8
Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030.
9
The efficacy of the ImmuKnow assay for evaluating the immune status in human immunodeficiency virus and hepatitis C virus-coinfected patients.
Transplant Proc. 2014 Apr;46(3):733-5. doi: 10.1016/j.transproceed.2013.11.119.
10
[Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study].
Enferm Infecc Microbiol Clin. 2005 Jun-Jul;23(6):340-8. doi: 10.1157/13076173.
引用本文的文献
1
Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort.
Liver Int. 2025 Jan;45(1):1-13. doi: 10.1111/liv.16203.
2
Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals.
Hepat Mon. 2016 Apr 18;16(4):e37089. doi: 10.5812/hepatmon.37089. eCollection 2016 Apr.
本文引用的文献
1
Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis.
Aliment Pharmacol Ther. 2014 May;39(10):1213-24. doi: 10.1111/apt.12718. Epub 2014 Mar 24.
2
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
Ann Intern Med. 2013 Dec 3;159(11):729-38. doi: 10.7326/0003-4819-159-11-201312030-00005.
3
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.
Lancet Infect Dis. 2013 Jul;13(7):597-605. doi: 10.1016/S1473-3099(13)70149-X. Epub 2013 Jun 12.
4
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.
Ann Intern Med. 2013 Jul 16;159(2):86-96. doi: 10.7326/0003-4819-159-2-201307160-00654.
5
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.
Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.
6
Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?
J Clin Virol. 2013 Feb;56(2):146-9. doi: 10.1016/j.jcv.2012.10.009. Epub 2012 Nov 11.
7
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.
Ann Intern Med. 2012 Dec 4;157(11):817-22. doi: 10.7326/0003-4819-157-9-201211060-00529.
8
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
JAMA. 2004 Dec 15;292(23):2839-48. doi: 10.1001/jama.292.23.2839.
9
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
N Engl J Med. 2004 Jul 29;351(5):451-9. doi: 10.1056/NEJMoa032653.
10
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
N Engl J Med. 2004 Jul 29;351(5):438-50. doi: 10.1056/NEJMoa040842.
Zotero 插件